Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway

References

• BuendiaMANeuveutCHepatocellular carcinomaCold Spring Harb Perspect Med201552a02144425646384
   PubMed Web of Science ®Google Scholar
• GordonRRNelsonPSCellular senescence and cancer chemotherapy resistanceDrug Resist Updat2012151–212313122365330
   PubMed Web of Science ®Google Scholar
• XuWShaoLZhouCWangHGuoJUpregulation of Nrf2 expression in non-alcoholic fatty liver and steatohepatitisHepatogastroenterology2011581122077208022024078
   PubMedGoogle Scholar
• LiuJWuKCLuYFEkuaseEKlaassenCDNrf2 protection against liver injury produced by various hepatotoxicantsOxid Med Cell Longev2013201330586123766851
   PubMed Web of Science ®Google Scholar
• WuKCLiuJJKlaassenCDNrf2 activation prevents cadmium-induced acute liver injuryToxicol Appl Pharmacol20122631142022677785
   PubMed Web of Science ®Google Scholar
• GuanLZhangLGongZFoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signalingHepatology20166361914192726857210
   PubMed Web of Science ®Google Scholar
• YaoJWeiXLuYChaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cellsBiochem Biophys Res Commun2016473486787327038543
   PubMed Web of Science ®Google Scholar
• FurfaroALPirasSDomenicottiCRole of Nrf2, HO-1 and GSH in neuroblastoma cell resistance to bortezomibPLoS One2016113e015246527023064
   PubMed Web of Science ®Google Scholar
• HouXBaiXGouX3′,4′,5′,5,7-pentamethoxyflavone sensitizes Cisplatin-resistant A549 cells to Cisplatin by inhibition of Nrf2 pathwayMol Cells201538539640125843086
   PubMed Web of Science ®Google Scholar
• SyuJPChiJTKungHNNrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxiaOncotarget2016712146591467226894974
   PubMedGoogle Scholar
• HongYBKangHJKwonSYNuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cellsPancreas201039446347220118824
   PubMed Web of Science ®Google Scholar
• QinXQiuCZhaoLMaslinic acid protects vascular smooth muscle cells from oxidative stress through Akt/Nrf2/HO-1 pathwayMol Cell Biochem20143901–2616724553817
   PubMed Web of Science ®Google Scholar
• DingYChenMWangMNeuroprotection by acetyl-11-keto-beta-Boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathwaySci Rep20144700225384416
   PubMed Web of Science ®Google Scholar
• ChenPZengHWangYLow dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteinsDrug Metab Dispos201442584485224510383
   PubMed Web of Science ®Google Scholar
• WozniakLSkapskaSMarszalekKUrsolic acid – a pentacyclic triterpenoid with a wide spectrum of pharmacological activitiesMolecules20152011206142064126610440
   PubMed Web of Science ®Google Scholar
• ZhaoCYinSDongYAutophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cellsAutophagy20139219620723182854
   PubMed Web of Science ®Google Scholar
• KimJHKimYHSongGYUrsolic acid and its natural derivative corosolic acid suppress the proliferation of APC-mutated colon cancer cells through promotion of beta-catenin degradationFood Chem Toxicol201467879524566423
   PubMed Web of Science ®Google Scholar
• WuJZhaoSTangQActivation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cellsJ Exp Clin Cancer Res2015349926362062
   PubMed Web of Science ®Google Scholar
• LengSHaoYDuDUrsolic acid promotes cancer cell death by inducing Atg5-dependent autophagyInt J Cancer2013133122781279023737395
   PubMed Web of Science ®Google Scholar
• PathakAKBhutaniMNairASUrsolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cellsMol Cancer Res20075994395517855663
   PubMed Web of Science ®Google Scholar
• LealASWangRSalvadorJAJingYSynthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cellsBioorg Med Chem201220195774578622959527
   PubMed Web of Science ®Google Scholar
• JuncoJJMancha-RamirezAMalikGUrsolic acid and resveratrol synergize with chloroquine to reduce melanoma cell viabilityMelanoma Res201525210311225647735
   PubMed Web of Science ®Google Scholar
• MengYLinZMGeNZhangDLHuangJKongFUrsolic acid induces apoptosis of prostate cancer cells via the PI3K/Akt/mTOR pathwayAm J Chin Med20154371471148626503559
   PubMed Web of Science ®Google Scholar
• MaJQDingJZhangLLiuCMProtective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathwayClin Res Hepatol Gastroenterol201539218819725459994
   PubMed Web of Science ®Google Scholar
• WangXBWangSSZhangQFInhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cellsOncol Rep201023121121519956884
   PubMed Web of Science ®Google Scholar
• GaoAMKeZPWangJNYangJYChenSYChenHApigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathwayCarcinogenesis20133481806181423563091
   PubMed Web of Science ®Google Scholar
• ChianSLiYYWangXJTangXWLuteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathwayAsian Pac J Cancer Prev20141562911291624761924
   PubMed Web of Science ®Google Scholar
• GalluzziLSenovillaLVitaleIMolecular mechanisms of cisplatin resistanceOncogene201231151869188321892204
   PubMed Web of Science ®Google Scholar
• MahmoudiMRabeSZBalali-MoodMKarimiGTabasiNRiahi-ZanjaniBUrsolic acid induced apoptotic cell death following activation of caspases in isolated human melanoma cellsCell Biol Int201539223023625230943
   PubMed Web of Science ®Google Scholar
• YangLJTangQWuJInter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cellsJ Exp Clin Cancer Res20163515927036874
   PubMedGoogle Scholar
• YangYJiangMHuJEnhancement of radiation effects by ursolic acid in BGC-823 human adenocarcinoma gastric cancer cell linePLoS One2015107e013316926177078
   PubMed Web of Science ®Google Scholar
• KimKHSeoHSChoiHSChoiIShinYCKoSGInduction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cellsArch Pharm Res20113481363137221910059
   PubMed Web of Science ®Google Scholar
• TaguchiKMotohashiHYamamotoMMolecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolutionGenes Cells201116212314021251164
   PubMed Web of Science ®Google Scholar
• LiuWTanXShuLUrsolic acid inhibits cigarette smoke extract-induced human bronchial epithelial cell injury and prevents development of lung cancerMolecules20121789104911522858837
   PubMed Web of Science ®Google Scholar
• HayesJDMcMahonMNRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancerTrends Biochem Sci200934417618819321346
   PubMed Web of Science ®Google Scholar
• JohnstoneTCSuntharalingamKLippardSJThe next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) ProdrugsChem Rev201611653436348626865551
   PubMed Web of Science ®Google Scholar
• PathakRKDharSA nanoparticle cocktail: temporal release of predefined drug combinationsJ Am Chem Soc2015137268324832726086212
   PubMed Web of Science ®Google Scholar